Has Glenda Moheeputh received payments from drug or device companies?

Yes. Drug and device makers reported $160,069 in general payments to Glenda Moheeputh across 390 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Glenda Moheeputh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Glenda Moheeputh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Glenda Moheeputh

Optometrist · Pembroke Pines, FLNPI 1689187676

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Alcon at 46.8% of the total. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$160,069in general payments, 2019–2025

Across 390 payments — averaging $410.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$75K
Johnson & Johnson Vision Care, Inc.$71K
Topcon Healthcare, Inc.$12K
Coopervision Inc.$554
AbbVie$376
Sight Sciences, Inc.$245
plus $1K from 11 others

What the payments were for

Consulting fees$75,16547%
Speaking & faculty fees$44,44028%
Travel & lodging$28,68418%
Food & beverage$11,7807%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	148	$74,845
Johnson & Johnson Vision Care, Inc.	184	$70,725
Topcon Healthcare, Inc.	29	$12,008
Coopervision Inc.	10	$554
AbbVie(2 entities)	3	$376
Sight Sciences, Inc.	2	$245
Sun Pharmaceutical Industries Inc.	2	$237
Bausch & Lomb Americas Inc.	2	$220
Biotissue Holdings Inc.	2	$151
Dompe US, Inc.	1	$140
Oyster Point Pharma, Inc.	1	$140
Maculogix, Inc.	1	$129
Aerie Pharmaceuticals, Inc.	1	$118
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$82
Rxsight Inc	1	$44
Glaukos Corporation	1	$28
Haag-streit USA, Inc.	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$160,069 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida →

Other optometrist in Pembroke Pines

Robert DavisPembroke Pines$217K
Amanda NanasyPembroke Pines$190K
Gabriela OlivaresPembroke Pines$168K
James HoffmanOrange Park$795K
April JasperWest Palm Beach$553K
Nora CothranLargo$505K
Michael SluskyNorth Port$384K
Katie SpearDefuniak Springs$361K
Karen HoffmanOrange Park$282K
Ashley RothMiami Beach$261K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →